Open access
Open access
Powered by Google Translator Translator

Cohort Study | Personalized progression prediction in patients with MGUS or smouldering multiple myeloma

9 Mar, 2023 | 13:59h | UTC

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study – The Lancet Haematology

Invited Commentary: The PANGEA model: catching the drift from precursor conditions to myeloma in individual patients – The Lancet Haematology

 

Commentary from the author on Twitter (thread – click for more)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.